Zapata Computing, Inc., the Industrial Generative AI company, announced that its scientists, in collaboration with Insilico Medicine, the University of Toronto, and St. Jude Children’s Research Hospital have demonstrated the first instance of a generative model running on quantum hardware outperforming state-of-the-art classical models in generating viable cancer drug candidates. The research points to a promising future of hybrid quantum generative AI for drug discovery using today’s quantum devices.